Effect of Negative Anion (Negative Ion) Addition to Oxygen Inhalation
There is no evidence-based recommendation to add negative ions to oxygen therapy in clinical practice, and major oxygen therapy guidelines do not address or recommend this intervention. The British Thoracic Society and American College of Physicians guidelines for oxygen use make no mention of ionized oxygen, focusing exclusively on standard oxygen delivery methods 1, 2.
Evidence Assessment
Guideline Evidence
The most recent and authoritative guidelines on oxygen therapy (BTS 2017 and ACP 2021) provide comprehensive recommendations for oxygen delivery systems including:
- Nasal cannulae
- Simple face masks
- Venturi masks
- Reservoir masks
- High-flow nasal oxygen
- Non-invasive ventilation
None of these guidelines mention negative ion therapy or ionized oxygen as a recognized or recommended modality 1, 2.
Research Evidence Limitations
While some experimental studies exist on ionized oxygen, they have significant limitations:
Small animal studies only: Research on negatively ionized oxygen shows mixed results in guinea pigs, with one study suggesting positively ionized oxygen (not negative) had less oxidative stress than negatively ionized oxygen after 60 hours 3
Contradictory findings: One small study in smokers suggested negatively ionized O₂ reduced carboxyhemoglobin more effectively than standard oxygen 4, but this was an in vitro and very limited human study with no clinical outcomes measured
Theoretical proposals only: A 2021 hypothesis paper suggested negative oxygen ion clusters might help COVID-19 patients, but this was purely speculative with no clinical trial data 5
No mortality or morbidity data: None of the research studies examined patient-centered outcomes like mortality, hospital length of stay, or quality of life
Clinical Recommendation
Use standard oxygen delivery systems as recommended by established guidelines 1, 2:
- Target SpO₂ 94-98% for most patients
- Target SpO₂ 88-92% for patients at risk of hypercapnia (COPD, obesity hypoventilation)
- Adjust delivery device and flow rate to maintain target saturation
- Consider high-flow nasal oxygen for acute hypoxemic respiratory failure when appropriate
Important Caveats
- Negative ion generators are not FDA-approved medical devices for oxygen therapy
- No standardized dosing, delivery methods, or safety monitoring exists
- The theoretical mechanisms proposed (neutralizing viral spike proteins, changing lung pH) lack clinical validation
- Standard oxygen therapy has decades of evidence supporting its safety and efficacy when properly prescribed and monitored 1
The absence of negative ion therapy from all major oxygen therapy guidelines reflects the lack of high-quality evidence supporting its clinical use. Stick with evidence-based oxygen delivery methods that have demonstrated benefits for patient outcomes.